Schizophrenia is a serious psychiatric condition with a lifetime prevalence of approximately 1%.
Introduction
Schizophrenia is a serious psychiatric condition with a lifetime prevalence of approximately 1%. 1 Although its etiology is still largely unknown, schizophrenia is thought to result from a complex interplay of a subset of genetic and environmental factors. 2, 3 Despite its high genetic component -estimated to be approximately 80% 1 -the identification and replication of genetic susceptibility factors for schizophrenia have proven challenging owing to the genetic and phenotypic heterogen eity that characterizes this disorder. 1, 2 In addition to multiple proteincoding genes that are im plicated in schizophrenia pathophysiology, recent evidence indicates that dysregulation of small, noncoding RNAs, such as microRNAs (miRNAs), may play an important role in the etiology of the disorder. 4 MicroRNAencoding genes are highly conserved across evolution and have been shown to be involved in various fundamental biological processes. 5 They regu late the expression of target messenger RNAs (mRNAs) by binding to their 3′untranslated region (UTR), causing either mRNA degradation or protein synthesis inhibition. 6, 7 Each miRNA affects many mRNAs, while indi vidual mRNAs can be targeted by several miRNAs. Some miRNAs are highly enriched in the brain or are even brain specific, suggesting their unique regulatory roles in neuronal function, 8 including the modulation of neuronal and synap tic plasticity 9, 10 and neuronal circuitry. 11, 12 In support of this notion, the miRNA target site density in synaptic mRNAs is twice as high as in nonsynaptic mRNAs. 13 Furthermore, there have been numerous studies implicating brain enriched miRNAs in the etiology of schizophrenia. For ex ample, a subset of brainenriched miRNA genes located within an imprinted cluster on chromosomal region 14q32 was differentially expressed in a large cohort of patients with schizophrenia. 14 In addition, a microdeletion of chro mosomal region 22q11.2, harboring the brainenriched miR 185, has been consistently linked to schizophrenia, and dele tion of the corresponding region in the mouse resulted in an altered development of neuronal dendrites and spines. 15 The most robust genetic evidence for the involvement of a miRNA in schizophrenia has emerged from a genomewide association study (GWAS) with a sample of approximately 50 000. 16 In this study, a singlenucleotide polymorphism (SNP; rs1625579) located within an intron of the miR137 host gene (MIR137HG) achieved genomewide sig nificance for association with schizophrenia.
Notably, rs1625579 (and hence miR137) has also been gen etically associated with a number of schizophrenia endo phenotypes, including cognitive deficits, negative symptoms, 17 brain activation, 18, 19 brain structure and age at disease onset. 20 Moreover, apart from having a strong genetic link with schizophrenia, miR137 is highly abun dant in hippocampal and cortical neurons, where it regu lates neuronal maturation and dendritic spine morpho genesis, 21 and more specifically in the synaptic compartment. 22 In addition, miR137 modulates the prolif eration and differentiation of murine adult neural stem cells, 23 and its overexpression results in decreased den dritic spine size. 21 Since disturbances in synaptic function and plasticity as well as in neuronal circuitry have also been associated with the onset and progression of schizo phrenia, 13, 24, 25 we hypothesized that miR137 is involved in modulating gene expression during synaptic plasticity and that miR137mediated regulation of plasticityrelated genes is disturbed in patients with schizophrenia. There fore, we conducted bioinformatics and literature analyses to generate a molecular network of interacting miR137 targets. In addition, transcriptomics data were derived from a rat neuronal plasti city model of somatosensory ex perience, and loss of miR137 function experiments in pri mary cortical neurons were performed to validate these interacting miR137 targets.
Methods
All experimental protocols and procedures were approved by the Animal Ethics Committee of the Radboud University Nij megen (the Netherlands) and were in accordance with the Dutch legislation. Supplementary descriptions of the procedures we used are provided in the Appendix (available at jpn.ca).
Human and mouse miR-137 target prediction
A particularly powerful aspect of miRNA function is the ability of individual miRNAs to regulate a multitude of mRNAs cod ing for proteins with related cellular functions. Therefore, we explored the possibility that miR137 has putative target genes with similar neuronal functions. Mature miR137 is highly con served across mammals, having exactly the same nucleotide se quence in humans, mice and rats. We used DIANAmicroT 3.0, a computational algorithm for miRNA target prediction (www .microrna.gr/microT), to generate a list of putative human and mouse miR137 targets (i.e., hsamiR137, mmumiR137). The DIANAmicro T 3.0 algorithm is based on several parameters calculated individually for each miRNA, and, as opposed to other commonly used miRNA prediction tools that use only conserved miRNA recognition/binding sites (e.g., TargetScan), this algorithm combines both conserved and nonconserved miRNA binding sites into a final prediction score, which correl ates with the signal to noise ratio (SNR) and hence provides an indication of the falsepositive rate of the prediction. 26, 27 The higher the prediction score, the lower the amount of false posi tives, and as a broad estimate, prediction scores of 19, 7.3 and 5 correspond to SNRs of 3, 2 and 1.5 and falsepositive rates of 33%, 50% and 66%, respectively. 26 In this respect, the DIANA algorithm is the only currently available miRNA target predic tion tool that also allows for a statistical prediction of the extent to which a predicted target is a true target. Hence, to obtain a list of predicted human and mouse miR137 targets with a pre dicted falsepositive rate of 50% at the most, we used a thresh old of at least 7.3 for the prediction score.
Functional classification of predicted human and mouse miR-137 targets
To detect significantly enriched gene categories in the pre dicted miR137 target genes/mRNAs, we used the Ingenuity Pathway Analysis software package (www.ingenuity.com). It uses the Ingenuity Knowledge Base, which is based on infor mation from published literature and many other sources, in cluding gene expression and gene annotation databases, to as sign genes to different groups and categories of functionally related genes. Each of these categories can be further divided into subcat egories. Ingenuity calculates single p values for the enrichment of each gene category using the righttailed Fisher exact test and taking into consideration both the total number of molecules from the analyzed data set and the total number of molecules linked to the same gene category according to the Ingenuity Knowledge Base. Furthermore, for each gene cat egory, a multiple testing corrected p value of enrichment, cal culated using the Benjamini-Hochberg correction, is provided.
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Measurement of miR-137 levels in a rat model of neuronal plasticity
Our initial studies have shown significant enrichment of miR137 in synaptic compartments of the mouse brain. 22 To further examine the significance of this finding and assess if miR137 levels are altered by synaptic/neuronal plasticity, we used a widely accepted in vivo model, the rat barrel cor tex, 28 to study experiencedependent changes in miR137 ex pression. In the barrel cortex, plasticity can be induced by modifying somatosensory input through simple manipula tions, such as exposing the animals to an enriched environ ment (EE), thus overstimulating the whiskertobarrel path way. 29 We used RNA samples from a previous study, derived from primary somatosensory (barrel) cortical sam ples from adult rats that had been placed into an EE to elicit cortical plasticity (see Vallès and colleagues 30 for details). Precursor (pre) and mature (mat) miR137 expression lev els in barrel cortex were determined by quantitative poly merase chain reaction (qPCR) immediately following the EE session and compared with levels measured in control rats. Significant differences in miR137 expression between EE and control rats were determined with a Student t test at a significance level of p < 0.05 using SPSS software version 17.0 (SPSS Inc.).
Identification of putative rat miR-137 targets involved in neuronal plasticity
We analyzed a list of putative miR137 targets involved in neur onal plasticity by comparing the putative list of human and mouse targets with the list of mRNAs that we previously found to be regulated in our rat neuronal plasticity model. This list of mRNAs regulated in rat barrel cortex after EE (170 mRNAs up regulated and 31 mRNAs downregulated) was obtained using microarray analysis (significance analysis of microarrays q ≤ 0.05 and fold change ≥ |1.25|) in our previous study. 30 As opposed to human and mouse miRNAs, the DIANAmicroT 3.0 algo rithm is not available for rat miRNAs. Therefore, in order to esti mate which of the putative human and mouse miR137 targets are also predicted to be rat miR137 targets, we subsequently searched the miRWalk database 31 for the "combined prediction score" of all putative miR137 targets that achieved a DIANA miR137 prediction score of at least 7.3 in humans and/or mice. This combined prediction score ranges from 1 to 4 and is com posed of the individual prediction scores -0 if the target is not predicted and 1 if the target is predicted -from the 4 currently available rat microRNA target prediction tools (i.e., miRanda, miRDB, TargetScan and miRWalk itself; www .umm.uni heidelberg.de/apps/zmf/mirwalk).
Regulation of neuronal plasticity-involved targets by miR-137 in rat cortical neurons
To determine whether the observed experiencedependent changes in the expression of the putative miR137 targets are mediated, at least in part, by miR137, we transfected sequence specific antimiR137 and nontargeting antimiR control (NT) into rat primary cortical neurons. Twentyfour hours after transfection, expression levels of all EEregulated mRNAs that are also putative miR137 targets were analyzed by qPCR in neurons transfected with antimiR137 or NT. The effects of antimiR137 treatment on mature miR137 levels were also as sessed in a comparable parallel experiment. Significant differ ences in expression between neurons transfected with anti miR137 and NT were analyzed with a Student t test at a significance level of p < 0.05 using SPSS software version 17.0. To correct p values for multiple testing 32 and to protect against type 1 error, p values with a false discovery rate (FDR) of 0.05 were calculated using an Excel macro. 33 
Generation of molecular network of neuronal plasticity genes regulated by miR-137
We generated a molecular network by integrating the results of the bioinformatics analyses with systematic literature searches for the function of the neuronal plasticity targets whose expression was putatively regulated by miR137 in rat cortical neurons. This was achieved through the molecular network building approach that we have previously applied to study the molecular basis of various neurodevelopmental disorders, including attentiondeficit/hyperactivity disorder 34 and autism spectrum disorders (ASDs).
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Results
Human and mouse miR-137 target prediction and functional classification of predicted targets
As described in the Methods section, using DIANAmicro T 3.0. with a cutoff of 7.3, we obtained a list of 1049 predicted human miR137 targets and 814 predicted mouse miR137 targets. The Ingenuity tool was subsequently used to identify significantly enriched gene categories within the predicted miR137 targets. Table 1 lists the 10 most significantly enriched biological func tions and canonical pathways within the predicted human and mouse miR137 targets. In both species, several of the identified enriched gene categories are essential for (normal) neuronal de velopment and function, including neuritogenesis, action poten tial of neurons and ephrin receptor signalling within the pre dicted human miR137 targets and neuro transmission, action potential of neurons, ephrin receptor signalling and axonal guidance signalling within the predicted mouse miR137 tar gets. These results are in accordance with those from a recent study by Wright and colleagues 36 in which bioinformatics analy ses were conducted on all human miR137 targets predicted by the TargetScan tool. However, the criteria they used to designate a gene/mRNA as a putative human miR137 target were much less stringent than the DIANA cutoff that we used in that they did not consider any statistical or other cutoff but included all genes/mRNAs that contained at least 1 conserved seedbinding site for human miR137 in their subsequent bioinformatics an alyses, as revealed by the TargetScan target predictions website. This approach suggests that a (much) larger proportion of genes serving as a starting point for analyses in the study by Wright and colleagues 36 than our study may have been false positives.
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Regulation of miR-137 expression and putative miR-137 targets in the rat barrel cortex following EE
We detected significantly reduced levels of premiR137 (~66% reduction; t test, p = 0.006) and matmiR137 (~50% reduction; t test, p = 0.034) in the barrel cortex of rats exposed to EE com pared with pre and matmiR137 levels in the barrel cortex of control animals (Fig. 1A) . Through applying the prediction criter ia for human, mouse and rat miR137 targets (see the Methods sec tion), we identified 14 putative miR137 target mRNAs that we previously found to be regulated among the transcriptomes ex amined in a rat neuronal plasti city model following EE 30 ( Table 2 ). The fact that all these predicted targets were upregulated in their mRNA levels is in keeping with the present finding that miR137 expression was downregulated following EE.
Effect of endogenous miR-137 silencing on the expression of EE-regulated putative miR-137 targets
To examine the influence of miR137 on the expression of the putative miR137 targets identified in the EE neuronal plasti city model, we have repressed endogenous miR137 function in pri mary cortical neurons in vitro using a sequencespecific anti miR137 inhibitor. This inhibitor significantly reduces miR137 levels (see the Appendix, Fig. S1 ). After miR137 decrease, we found a significant increase in the levels of 5 out of the 14 (36%) predicted and tested mRNA targets, namely Egr2, Dusp1, Ptgs2, Dusp4 and Sgk1 (t test followed by FDR multiple testing correc tion; all p < 0.05, corrected; Fig. 1B) . Klf4, Crem, Klf2, and Obfc2a levels increased to a lesser and borderline significant extent (t test followed by FDR multiple testing correction, all p < 0.10), while the mRNA levels of Med14, Spty2d1, Irs2 and Usp38 re mained unchanged. The finding that Dio2 mRNA levels were significantly decreased in neurons transfected with antimiR137 (t test followed by FDR multiple testing correction; p < 0.05, cor rected) may be due to additional posttranscriptional regulatory mechanisms potentially exerting secondary signalling effects. These results suggest that miR137, at least partially, modulates the expression of a significant number of genes in the rat barrel cortex upon induction of neuronal plasticity by EE.
Generation of molecular network of neuronal plasticity genes regulated by miR-137
Bioinformatics analyses of the 5 putative miR137 targets up regulated in both the EE neuronal plasticity model and follow ing lossof function of endogenous miR137 in vitro showed that some of the most significantly enriched functional gene cat egories are directly related to the normal development and/or function of the nervous system (i.e., the biological functions epi leptic seizure, behaviour and spatial memory; Table 3 ). In addi tion, 2 of the 6 significantly enriched canonical pathways (gluco corticoid receptor signalling and aldosterone signalling in epithelial cells) point toward a role for these miR137 targets in corticosteroidrelated signalling. Furthermore, glucocorticoid re ceptor signalling -the most significantly enriched canonical pathway within the 5 targets -and protein kinase A signalling are the only 2 pathways that were significantly enriched in all 3 gene enrichment analyses that we conducted (i.e., the analyses of the predicted human and mouse miR137 targets and of the 5 putative miR137 targets that were upregulated following the antagomir mediated loss of function of miR137 levels in pri mary neurons in vitro; Tables 1 and 3) . By integrating the results of the bioinformatics analyses with systematic literature searches for the functions of the proteins encoded by the 5 confirmed miR137 target mRNAs, we built a molecular network that contains putative neuronal plasticityrelated miR137 targets (i.e., COX2 [encoded by PTGS2], DUSP1, DUSP4, EGR2, SGK1) and that may be involved in regulating neuronal plasticity through modulating glucocorti coid receptor-dependent signalling (Fig. 2) . This outcome pro vides a testable model that requires further confirmation in follow up studies. In addition to the 5 miR137 targets, we placed the proteins encoded by 3 known miR137 targets that have previously yielded genomewide significant association with schizophrenia (i.e., CACNA1C, TCF4 and ZNF804A), 37, 38 as well as 5 neuronal plasticity-related proteins that function ally link the other network components (i.e., BDNF, DDIT3, EGR1, the glucocorticoid receptor itself and GRIN1) in the gen erated network (Fig. 2) . Interestingly, the DIANA tool revealed Fig. 1: (A) Expression levels of microRNA-137 (miR-137) in the barrel cortex upon exposure of the rats to environmental enrichment (EE). We used a quantitative polymerase chain reaction (qPCR) assay to assess levels of both precursor (pre-) and mature (mat-) miR-137 in total RNA samples from the barrel cortex of rats exposed to EE and control animals. Levels of pre-and mat-miR-137 are expressed relative to U6 small nuclear RNA, used as an internal control; the scale of relative expression is ×10 −5 . Error bars represent the standard error of the mean (SEM) for control (n = 6) and EE (n = 12) measurements. Results are from 2 and 4 independent pooled samples (n = 2-3 animals per pool), respectively, assessed in triplicate using unpaired 2-tailed Student t tests (*p < 0.05, **p < 0.01). (B) Expression levels of the putative miR-137 target messenger RNAs (mRNAs) in a miRNA loss of function experiment. Primary rat cortical neurons were transfected with anti-miR-137 or, as a control, nontargeting short oligonucleotides (NT). Expression levels of predicted miR-137 target mRNAs were quantified by qPCR analysis 24 hours after oligonucleotide transfection. The putative miR-137 target mRNAs were previously found to be associated with activity-dependent plasticity in the rat barrel cortex. 30 Error bars represent the SEM for independ ent experiments (n = 4); unpaired 2-tailed Student t test followed by Benjamini-Hochberg false discovery rate (FDR) multiple testing correction, 32 #p < 0.10, FDR-corrected; *p < 0.05, FDR-corrected; **p < 0.01, FDR-corrected; ***p < 0.001, FDR-corrected. DIANA = DNA intelligent analysis; SAM = significance analysis of microarrays. *For each gene, the fold change and SAM q value from our previous study of environmental enrichment-induced mRNA expression changes are shown. 30 †Regulated after miR-137 inhibition in vitro (as shown in Fig. 1B ).
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that the glucocorticoid receptor (encoded by NR3C1) is a pre dicted target of both human miR 137 (prediction score: 7.72) and mouse miR137 (prediction score: 18.41). The network is described in detail in the Appendix, and the current knowledge about the functions of the individual net work proteins is delineated. Remarkably, except for DDIT3, all proteins in the network have been implicated in the etiology of schizophrenia through genetic evidence and/or mRNA/protein expression data (see the Appendix, Table S1 ), which provides a further functional and molecular link between miR137 dependent dysregulation and schizophrenia.
Discussion
One of the main cognitive deficits observed in patients with schizophrenia is altered perception, resulting in hallucinations and delusions. 39 While visual and auditory perception deficits in these patients have been well described, recent studies sug gest that deficits in all the other sensory systems (olfactory, gus tative, somatosensory) are also associated with schizophrenia pathology. 40 Interestingly, sensory training improves cognitive abilities in patients with schizophrenia and results in changes of peripheral biomarker levels of neuronal plasticity. 41 Accord ingly, sensory stimulation through EE counteracted behaviours related to schizophrenia (e.g., stereotypical behaviour, impaired prepulse inhibition) in a mouse model of the disorder. 42 Since the somatosensory system is the dominant sensory system in rodents, with a clear somatotopic representation of the whis kers (the main somatosensory organs) in the primary somato sensory cortex, we chose it to study the molecular basis of al tered perception induced by sensory training in rodents. 28 In the present study, we used bioinformatics and literature analyses to generate a molecular network of potentially inter acting miR137 targets during the induction of plasticity in the rat barrel cortex. We also identified 5 putative miR137 target mRNAs by combining transcriptomics data derived from the rat neuronal plasticity model of somatosensory experience with the results of loss of miR137 function in rat primary cortical neurons. The downregulation of miR137 following EE that we observed is in keeping with other findings demonstrating that miRNA levels can be modulated upon the induction of long term synaptic plasticity 43 (e.g., for miR132 44 and for miR485 during homeostatic plasticity 45 ). Furthermore, a number of miRNAs are capable of finetuning the expression of synaptic plasticity proteins involved in actin cytoskeleton dynamics, or mRNA transport, resulting in spine morphogenesis. [46] [47] [48] The molecular network that we have constructed includes the proteins encoded by the 5 miR137 target mRNAs found to be upregulated in the rat barrel cortex following EE, as well as 3 previously validated miR137 target proteins. Notably, all but 1 protein (DDIT3) within this network have been linked to schizophrenia through direct genetic evidence and/or expres sion data. Moreover, the proposed miR137regulated net work is involved in experiencedependent neuronal plasticity through modulating glucocorticoid receptor-dependent sig nalling, a pathway that recently has been functionally linked to synaptic/neuronal plasticity [49] [50] [51] [52] and directly associated with schizophrenia. 53, 54 The glucocorticoid receptor pathway has been shown previously to be regulated both in a direct and indirect fashion by miR124a and miR18, 55 whereas our results suggests that this pathway, at least partially, is regu lated through miR137. Furthermore, combined with the aforementioned findings from other groups, our results sug gest a direct functional link between impaired miR137 dependent regulation and schizophrenia through glucocorti coid receptor signalling.
Interestingly, although less strongly, miR137 has been gen etically linked to a number of other brain disorders, namely Al zheimer disease 56 and 2 neurodevelopmental disorders other than schizophrenia, intellectual disability 22 and ASDs. 57 Nota bly, all these disorders are genetically and functionally associ ated with dysregulated stress and hypothalamic-pituitaryadrenal axis responses, which may involve, among other pathways, altered glucocorticoid receptor signalling 50, [58] [59] [60] [61] and impaired synaptic plasticity. [62] [63] [64] [65] This suggests that dysregula tion of miR137 -and possibly impaired glucocorticoid recep tor signalling -may lead to impaired synaptic plasticity, rep resenting a common mechanism underlying cognitive deficits associated with clinically distinct neurologic disorders. †Categories that are directly related to the (normal) development and/or function of the nervous system. ‡Significance was determined from a single test p value calculated using the righttailed Fisher exact test and taking into consideration both the total number of molecules from the analyzed data set and the total number of molecules linked to the same gene category according to the Ingenuity Knowledge Base. Adjusted significance was determined from multiple test-corrected p values using the Benjamini-Hochberg correction (only categories reaching a corrected statistical significance of p < 0.05 are shown).
Finally, our finding that EEmediated sensory experience caused a significant downregulation of miR137 expression in the rat barrel cortex, along with the finding that EE counter acts schizophreniarelevant behaviours in a mouse schizo phrenia model (e.g., stereotypical behaviour, impaired pre pulse inhibition), 42 suggests that reducing brain miR137 levels may lower the risk for schizophreniarelated behaviour. In this respect, it is of interest to note that in the human pre frontal cortex miR137 levels significantly decrease with age, with the most prominent decline in expression being ob served in or just after late adolescence, 66 which is the window of onset for schizophrenia. This notion indicates that insufficient Fig. 2 : A microRNA-137 (miR-137)-regulated protein network that is implicated in neuronal plasticity through modulating glucocorticoid receptor-dependent signalling. The 5 novel miR-137 targets from this study (DUSP1; DUSP4; EGR2; PTGS2, which encodes the COX2 protein; and SGK1), as well as 3 previously validated miR-137 targets encoded by genes with a genome-wide significant association with schizophrenia (CACNA1C, TCF4 and ZNF804A), are depicted in yellow. The glucocorticoid receptor (GR; shown in blue) protein (encoded by NR3C1) is a predicted target of miR-137 in humans (DIANA prediction score: 7.72) and mice (DIANA prediction score: 18.41). Furthermore, all proteins with a red border have been implicated in schizophrenia through direct genetic evidence and/or messenger RNA/protein expression data (see the Appendix, Table S1 ). The network is described in full detail in the Appendix, and the current knowledge about the functions of the network proteins is presented. 
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decline in miR137 during adolescence may contribute to the pathoetiology of schizophrenia. In support of this hypothesis, a recent study found that the schizophrenia risk allele of rs1625579 (the miR137linked SNP) is significantly associated with a lower miR137 expression level in postmortem prefron tal cortex tissue of the control group but not the schizophrenia group. 67 Importantly, beneficial effects of EE have also been reported in rodent models of Alzheimer disease, 68, 69 intellec tual disability 70 and ASDs, 71, 72 raising the intriguing possibility that modulating miR137 levels may result in altered pheno types of these 3 miR137linked neurologic disorders. 22, 56, 57 
Limitations
We used the DIANA algorithm to generate a list of predicted human and mouse miR137 targets. Although the algorithm is one of the best currently available tools to predict miRNA tar gets 26, 27 it does not predict miRNA targets in rats, our animal model of choice to study the expression of miR137 and its pre dicted targets in the context of neuronal plasticity. Hence, to esti mate which of the putative human and mouse miR137 targets are also predicted to be targets in rats, we used the miRWalk data base to obtain a combined prediction score using the 4 cur rently available tools that predict targets of rat miRNA. This score indicated that 2 of the 5 predicted miR137 targets regu lated by neuronal plasticity and upregulated after loss of miR 137 function experiments, Ptgs2 and Dusp4, are not predicted targets in rats, which implies that the upregulation of these tar gets may be due to indirect effects. Therefore, followup studies should be performed to assess whether these 2 predicted targets are indeed direct miR137 targets in the rat. In line with this, gain of miR137 function experiments may also add relevant in formation. Although these points should be taken into consider ation, our findings are very much in keeping with those of other studies and strongly support the important role of miR137 in neuronal plasticity and the etiology of schizophrenia.
Conclusion
The outcomes of our studies suggest a critical role of miR137 in modulating experiencedependent cortical plasticity via a glucocorticoid receptor signalling pathway. As such, the data provide a scope for developing novel molecular therapies aimed at lowering brain levels of miR137 in order to treat schizophrenia and other miR137linked disorders.
